Details concerning BSAR exercise

As part of the ongoing proceedings, Europlasma recalls that the share price as well as BSAR B and C of the Company have been suspended since 20 March 2019.

Read the press release (in French)


Number of shares and voting rights as at 31/03/2019

Europlasma declares the number of voting rights and shares comprising its share capital as at 31st March.

Read the press release


Europlasma shares trading is suspended pending a press release

Europlasma asked Euronext Paris to suspend the trading of its shares (FR0000044810-ALEUP) from today at 9:00am (Paris time).

Read the press release (in French)


Number of shares and voting rights as at 28/02/2019

Europlasma declares the number of voting rights and shares comprising its share capital as at 28th February.

Read the press release


Termination of the liquidity contract

The company announces that the liquidity contract entrusted to Kepler Cheuvreux ended on 5 February 2019.

Read the release


Number of shares and voting rights as at 31/01/2019

Europlasma declares the number of voting rights and shares comprising its share capital as at 31st January.

Read the press release


Europlasma shares trading is suspended pending a press release

Europlasma asked Euronext Paris to suspend the trading of its shares (FR0000044810-ALEUP) from today before the opening of the stock exchange.

Read the press release (in French)


Call to a General Meeting of Shareholders

The shareholders of are informed that they will be convened in a Extraordinary General Meeting on 25 February, 2019.

Read the notice (in French)


Number of shares and voting rights as at 31/12/2018

Europlasma declares the number of voting rights and shares comprising its share capital as at 31st December.

Read the press release


Half-year report on liquidity contract as at 31/12/2018

Under the liquidity contract agreed between the company and Kepler Cheuvreux, as at 31 December 2018.

Read the release